BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21710236)

  • 1. Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma.
    Qi F; Wei Y; Wu M; Sun Y; Xie Y; Lin N; Liu W; Wang W; Song Y; Zhu J
    Ann Hematol; 2024 May; 103(5):1643-1653. PubMed ID: 38191717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum IL-6 and total IgEAb are associated with poor survival in natural killer/T-cell lymphoma.
    Hui Y; Gao Y; Li J; Kong Q; Duan Y; Liu H; Liu F; Sang H
    Ann Hematol; 2024 Apr; 103(4):1285-1292. PubMed ID: 38095656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular NK/T-cell lymphoma: a series of four cases.
    Yan J; Zhang F; Luo D; Yao S; Chen Y; Xu F; Luo X; He J; Liu Y
    Int J Clin Exp Pathol; 2017; 10(9):9541-9550. PubMed ID: 31966830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations.
    Chang YC; Tsai HJ; Huang TY; Su NW; Su YW; Chang YF; Chen CG; Lin J; Chang MC; Chen SJ; Chen HC; Lim KH; Chang KC; Kuo SH
    Ann Hematol; 2024 Apr; ():. PubMed ID: 38671297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
    Wei YC; Liu WX; Qi F; Zhang CG; Zheng BM; Xie Y; Chen B; Zhang D; Liu WP; Fang H; Chai Y; Qi SN; Li YX; Wang WH; Song YQ; Zhu J; Dong M
    Ann Hematol; 2024 Jan; 103(1):163-174. PubMed ID: 37817010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the peripheral blood inflammatory indices and modified nomogram-revised risk index on survival of Extranodal Nasal-Type Natural Killer/T-Cell lymphoma.
    Hou Q; Li H; Liang Y; Yao N; Cao X; Liu J; Sun B; Feng P; Zhang W; Cao J
    Cancer Biomark; 2024; 39(1):27-36. PubMed ID: 37522199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between c-Myc Expression with Clinicopathological Features in T And NK Cell Lymphomas.
    Hasenan N; Mohd Isa SA; Hussain FA
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):4011-4016. PubMed ID: 34967583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients.
    Shi Q; Shen R; Wang CF; Fan X; Qian Y; Ou-Yang BS; Zhao Y; Leboeuf C; Janin A; Cheng S; Wang L; Zhao WL
    Mediators Inflamm; 2017; 2017():7960907. PubMed ID: 29109622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram.
    Cao J; Lan S; Shen L; Si H; Xiao H; Yuan Q; Li X; Li H; Guo R
    Sci Rep; 2017 Sep; 7(1):10982. PubMed ID: 28887511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of survival of natural killer/T-cell lymphoma, nasal type, in a non-Asian population: a single cancer centre experience.
    Vásquez J; Serrano M; Lopez L; Pacheco C; Quintana S
    Ecancermedicalscience; 2016; 10():688. PubMed ID: 27994644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent IMRT and weekly cisplatin followed by GDP chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell lymphoma.
    Ke QH; Zhou SQ; Du W; Liang G; Lei Y; Luo F
    Blood Cancer J; 2014 Dec; 4(12):e267. PubMed ID: 25501024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression levels of TWIST1 are associated with the clinicopathological stage of B-cell non-Hodgkin lymphoma.
    Jia C; Liang L; Yang L; Zhao F; Bai J
    Exp Ther Med; 2014 Nov; 8(5):1489-1493. PubMed ID: 25289047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type.
    Yamazaki E; Tomita N; Koyama S; Ogusa E; Ishii Y; Takahashi H; Miyashita K; Matsuura S; Tachibana T; Takasaki H; Takemura S; Fujimaki K; Sakai R; Fujisawa S; Ishigatsubo Y
    Med Oncol; 2014 Sep; 31(9):149. PubMed ID: 25108598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?
    Lunning MA; Horwitz S
    Curr Treat Options Oncol; 2013 Jun; 14(2):212-23. PubMed ID: 23568456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.
    Xu PP; Wang Y; Shen Y; Wang L; Shen ZX; Zhao WL
    Med Oncol; 2012 Sep; 29(3):2176-82. PubMed ID: 21710236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extranodal NK/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 cases.
    Su YJ; Wang PN; Chang H; Shih LY; Lin TL; Kuo MC; Chuang WY; Wu JH; Tang TC; Hung YS; Dunn P; Kao HW
    Eur J Haematol; 2018 Sep; 101(3):379-388. PubMed ID: 29908084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.